Skip to main content

Market Overview

Analyst: Greek Crisis An 'Opportunity' To Buy Europe, Biotech & SMID-Cap Discretionary


Technical tea leaves suggest buying European stocks, biotech and small-to mid-cap consumer discretionary companies, an analyst said Monday.

Ari H. Wald, a technical analyst at Oppenheimer, also recommended selling small-to mid-cap utilities.

Wald recommended the Euro Stoxx 50, an index of blue-chip Eurozone stocks, "because we're encouraged about the development of a long-term relative base versus the MSCI World Index."

An exchange-traded fund that tracks the index, SPDR EURO STOXX 50 ETF (NYSE: FEZ), was off 4 percent Monday.

Wald also suggested biotech stocks, because he said the sector has averaged a 9.9 percent gain in the third quarter, over the past 25 years.

"We recommend buying the iShares Biotech ETF (NASDAQ: IBB) into its $357-$368 support range," Wald said.

The fund traded recently at $364.27, down $8.51.

Small- and mid-cap consumer discretionary stocks are "breaking higher on a relative basis," according to Wald.

From the consumer group, Wald recommended Jarden Corp (NYSE: JAH), Kirkland's, Inc. (NASDAQ: KIRK) and Live Nation Entertainment, Inc. (NYSE: LYV).

Wald also recommended three restaurant companies: Jack in the Box Inc. (NASDAQ: JACK), Sonic Corporation (NASDAQ: SONC) and Wendys Co (NASDAQ: WEN).

Among utilities, which Wald said "continue to break down on a relative basis, he suggested selling Black Hills Corp (NYSE: BKH) and National Fuel Gas Co. (NYSE: NFG).

The S&P 500 is down about 2 percent in the past five trading days.

Wald said that on average when the S&P 500 ends June on a downward trend, it has traded positively during July only 41 percent of the time since 1950.


Related Articles (FEZ + IBB)

View Comments and Join the Discussion!

Posted-In: Ari H. Wald OppenheimerAnalyst Color Technicals Reiteration Analyst Ratings Trading Ideas

Latest Ratings

CMSMorgan StanleyMaintains66.0
CHTRMorgan StanleyMaintains730.0
CFGMorgan StanleyMaintains56.0
CBSHMorgan StanleyMaintains67.0
BEMorgan StanleyMaintains27.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at